Q: What is Abilify Maintena used for?

Abilify Maintena is used to treat schizophrenia and for the maintenance treatment of bipolar I disorder .

Q: How does Abilify Maintena work?

Mechanism of Action Abilify Maintena belongs to a class of medications known as atypical antipsychotics. While the exact way it works is not fully understood, it is believed to help regulate the activity of dopamine and serotonin . These are natural substances, called neurotransmitters, that allow brain cells to communicate with each other. In the brain, this medication is thought to act as a stabilizer. It can help increase chemical activity when levels are too low or decrease activity when levels are too high. By balancing these neurotransmitters, the medication helps improve thinking, mood, and behavior. Extended-Release Delivery Abilify Maintena is an extended-release injectable suspension, which means it is designed to stay in the body for a long period. This delivery method differs from daily oral medications in several ways: Slow Release: After the medication is injected into the muscle, it dissolves slowly and enters the bloodstream gradually over several weeks. Consistent Levels: The slow-release process helps maintain a steady level of the medication in the body, which can help provide continuous symptom control. Long-Term Action: Because the medication remains active in the system for a long time, it is typically administered by a healthcare professional only once every month.

Q: What are the active ingredients in Abilify Maintena?

The active ingredient in Abilify Maintena is Aripiprazole .

Q: What are the side effects of Abilify Maintena?

Common side effects of Abilify Maintena may include: Weight gain Akathisia Injection site pain and others. Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Abilify Maintena and how do I take it?

How It Is Given Abilify Maintena is an extended-release injectable suspension that must be administered by a healthcare professional in a medical setting. It is not designed for self-administration. The medication is given as an intramuscular injection, usually into the muscle of the buttock or the upper arm. Because this is a long-acting formulation, it is typically administered once every month. Your healthcare provider will determine the appropriate injection site and schedule based on your medical history and response to the medication. Starting Treatment When you first begin treatment with Abilify Maintena, your healthcare provider may instruct you to continue taking aripiprazole by mouth for a short period. This overlap ensures there is enough medication in your system while the long-acting injection begins to work effectively. Missed Doses It is important to receive your injection on a regular schedule to maintain the effectiveness of the treatment. If you miss an appointment for your dose, contact your healthcare provider immediately to reschedule. Your doctor will advise you on the necessary steps to get back on your regular dosing schedule.

Q: Is Abilify Maintena safe during pregnancy and breastfeeding?

Pregnancy It is not fully known how Abilify Maintena affects human pregnancy. However, taking antipsychotic medications during the last three months (third trimester) of pregnancy may cause problems in the newborn after delivery. These complications can include: Withdrawal symptoms Breathing difficulties Feeding problems Tremors or muscle stiffness Excessive sleepiness or agitation If you become pregnant while receiving this medication, it is important to talk to your healthcare provider. Do not stop the treatment without medical guidance, as untreated mental health conditions can also pose risks to both the parent and the baby. There is a pregnancy registry available to monitor the health of individuals who take psychiatric medications during pregnancy. Breastfeeding Aripiprazole, the active ingredient in Abilify Maintena, is known to pass into breast milk. Because of the potential for serious side effects in a nursing infant, a decision should be made whether to discontinue breastfeeding or to discontinue the medication. Healthcare providers typically weigh the importance of the drug to the parent's health against the potential risks to the infant when making this recommendation.

Q: What forms and strengths does Abilify Maintena come in?

Available Forms Abilify Maintena is provided as a long-acting injectable suspension. It is available in two primary delivery systems: Extended-release injectable suspension: This form consists of a vial containing a sterile powder that must be mixed with sterile water before administration. Pre-filled dual-chamber syringe: This system contains both the medication powder and the sterile water in separate chambers within a single syringe for reconstitution. This medication is intended for intramuscular use only and is typically administered into the deltoid or gluteal muscle.

Q: What is the FDA approval status of Abilify Maintena?

FDA Approval History Abilify Maintena was first approved by the U.S. Food and Drug Administration (FDA) in February 2013 for the treatment of schizophrenia in adults. In 2017, the FDA expanded its approved indications to include the maintenance treatment of bipolar I disorder in adults as a monotherapy. Boxed Warning The FDA requires a boxed warning for Abilify Maintena, which is the most serious type of warning for prescription medications. This warning states that elderly patients with dementia-related psychosis who are treated with antipsychotic drugs are at an increased risk of death. Abilify Maintena is not approved for the treatment of patients with dementia-related psychosis. Impulse-Control Warnings In 2016, the FDA issued a safety communication warning that aripiprazole, the active ingredient in Abilify Maintena, can lead to new or worsening impulse-control problems. These compulsive behaviors may include: Uncontrollable gambling Binge eating Compulsive shopping Increased sexual urges According to the FDA, these urges typically stop when the medication is discontinued or the dose is reduced. Patients and caregivers are advised to monitor for these behavioral changes, as they may not be recognized as abnormal without close observation. Administration Requirements As a regulatory requirement for safety and efficacy, Abilify Maintena must be administered only by a healthcare professional. It is provided as an extended-release injectable suspension and is typically administered once every month.

Question 1

What is Abilify Maintena?

Accepted Answer

Abilify Maintena is an extended-release version of the medication aripiprazole. It works by altering the activity of natural substances in the brain, such as dopamine and serotonin, to help restore chemical balance.

This medication is part of a group of drugs known as atypical antipsychotics. It is designed to release the active ingredient slowly into the system over time to maintain consistent levels in the body.

Question 2

What is Abilify Maintena used for?

Accepted Answer

Abilify Maintena is used to treat schizophrenia and for the maintenance treatment of bipolar I disorder.

Question 3

How does Abilify Maintena work?

Accepted Answer

Mechanism of Action

Abilify Maintena belongs to a class of medications known as atypical antipsychotics. While the exact way it works is not fully understood, it is believed to help regulate the activity of dopamine and serotonin. These are natural substances, called neurotransmitters, that allow brain cells to communicate with each other.

In the brain, this medication is thought to act as a stabilizer. It can help increase chemical activity when levels are too low or decrease activity when levels are too high. By balancing these neurotransmitters, the medication helps improve thinking, mood, and behavior.

Extended-Release Delivery

Abilify Maintena is an extended-release injectable suspension, which means it is designed to stay in the body for a long period. This delivery method differs from daily oral medications in several ways:

Slow Release: After the medication is injected into the muscle, it dissolves slowly and enters the bloodstream gradually over several weeks.
Consistent Levels: The slow-release process helps maintain a steady level of the medication in the body, which can help provide continuous symptom control.
Long-Term Action: Because the medication remains active in the system for a long time, it is typically administered by a healthcare professional only once every month.

Question 4

What are the active ingredients in Abilify Maintena?

Accepted Answer

The active ingredient in Abilify Maintena is Aripiprazole.

Question 5

What are the side effects of Abilify Maintena?

Accepted Answer

Common side effects of Abilify Maintena may include:

Weight gain
Akathisia
Injection site pain
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Abilify Maintena?

Accepted Answer

Abilify Maintena belongs to the atypical antipsychotic drug class.

Question 7

What is the dosage of Abilify Maintena and how do I take it?

Accepted Answer

How It Is Given

Abilify Maintena is an extended-release injectable suspension that must be administered by a healthcare professional in a medical setting. It is not designed for self-administration. The medication is given as an intramuscular injection, usually into the muscle of the buttock or the upper arm.

Because this is a long-acting formulation, it is typically administered once every month. Your healthcare provider will determine the appropriate injection site and schedule based on your medical history and response to the medication.

Starting Treatment

When you first begin treatment with Abilify Maintena, your healthcare provider may instruct you to continue taking aripiprazole by mouth for a short period. This overlap ensures there is enough medication in your system while the long-acting injection begins to work effectively.

Missed Doses

It is important to receive your injection on a regular schedule to maintain the effectiveness of the treatment. If you miss an appointment for your dose, contact your healthcare provider immediately to reschedule. Your doctor will advise you on the necessary steps to get back on your regular dosing schedule.

Question 8

Is Abilify Maintena safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is not fully known how Abilify Maintena affects human pregnancy. However, taking antipsychotic medications during the last three months (third trimester) of pregnancy may cause problems in the newborn after delivery. These complications can include:

Withdrawal symptoms
Breathing difficulties
Feeding problems
Tremors or muscle stiffness
Excessive sleepiness or agitation

If you become pregnant while receiving this medication, it is important to talk to your healthcare provider. Do not stop the treatment without medical guidance, as untreated mental health conditions can also pose risks to both the parent and the baby. There is a pregnancy registry available to monitor the health of individuals who take psychiatric medications during pregnancy.

Breastfeeding

Aripiprazole, the active ingredient in Abilify Maintena, is known to pass into breast milk. Because of the potential for serious side effects in a nursing infant, a decision should be made whether to discontinue breastfeeding or to discontinue the medication. Healthcare providers typically weigh the importance of the drug to the parent's health against the potential risks to the infant when making this recommendation.

Question 9

What forms and strengths does Abilify Maintena come in?

Accepted Answer

Available Forms

Abilify Maintena is provided as a long-acting injectable suspension. It is available in two primary delivery systems:

Extended-release injectable suspension: This form consists of a vial containing a sterile powder that must be mixed with sterile water before administration.
Pre-filled dual-chamber syringe: This system contains both the medication powder and the sterile water in separate chambers within a single syringe for reconstitution.

This medication is intended for intramuscular use only and is typically administered into the deltoid or gluteal muscle.

Question 10

What is the FDA approval status of Abilify Maintena?

Accepted Answer

FDA Approval History

Abilify Maintena was first approved by the U.S. Food and Drug Administration (FDA) in February 2013 for the treatment of schizophrenia in adults. In 2017, the FDA expanded its approved indications to include the maintenance treatment of bipolar I disorder in adults as a monotherapy.

Boxed Warning

The FDA requires a boxed warning for Abilify Maintena, which is the most serious type of warning for prescription medications. This warning states that elderly patients with dementia-related psychosis who are treated with antipsychotic drugs are at an increased risk of death. Abilify Maintena is not approved for the treatment of patients with dementia-related psychosis.

Impulse-Control Warnings

In 2016, the FDA issued a safety communication warning that aripiprazole, the active ingredient in Abilify Maintena, can lead to new or worsening impulse-control problems. These compulsive behaviors may include:

Uncontrollable gambling
Binge eating
Compulsive shopping
Increased sexual urges

According to the FDA, these urges typically stop when the medication is discontinued or the dose is reduced. Patients and caregivers are advised to monitor for these behavioral changes, as they may not be recognized as abnormal without close observation.

Administration Requirements

As a regulatory requirement for safety and efficacy, Abilify Maintena must be administered only by a healthcare professional. It is provided as an extended-release injectable suspension and is typically administered once every month.

Question 11

What should I know about Abilify Maintena and weight gain?

Accepted Answer

Weight Gain as a Side Effect

Weight gain is a documented side effect associated with Abilify Maintena. Clinical data indicates that while many people experience some change in weight, the amount gained can vary significantly between individuals. While aripiprazole is often associated with less weight gain than some other atypical antipsychotics, it remains a common concern for those using the long-acting injectable form.

Why Weight Gain Occurs

Antipsychotic medications can influence the body's metabolism and appetite regulation. Some individuals may experience increased hunger or changes in how their body processes energy while receiving these injections. Because Abilify Maintena is a long-acting medication, these effects may persist throughout the duration of the treatment cycle.

Monitoring and Management

Because of the potential for weight changes, healthcare providers generally implement a monitoring plan that includes:

Regular Weigh-ins: Tracking weight and body mass index (BMI) during scheduled injection appointments.
Metabolic Screening: Periodic blood tests to monitor cholesterol levels and blood sugar, as weight gain can sometimes be linked to other metabolic changes.
Lifestyle Adjustments: Guidance on maintaining a balanced diet and regular physical activity to help manage weight.

It is important to discuss any significant or rapid weight changes with a healthcare provider. They can help determine if the weight gain is related to the medication and provide strategies for management or discuss alternative treatment options if necessary.

Abilify Maintena

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Abilify Maintena

Hospitals.net Disclosure